Resources
68 Results (showing 51 - 60)
Results sorted by posted date (oldest first)
Results sorted by posted date (oldest first)
Posted 10/26/2021 (updated 4/3/2024)
Posted 3/9/2022 (updated 3/27/2024)
IMPORTANCE Thousands of pregnant people with opioid use disorder (OUD) enter US jails annually,
yet their access to medications for OUD (MOUD) that meet the standard of care (methadone and/or
buprenorphine) is unknown.
OBJECTIVE To assess the availability of MOUD for the treatment of pregnant individuals with OUD
in US jails.
Posted 3/15/2022 (updated 3/27/2024)
Pre- Pregnancy fact sheet. Information for Providers
Posted 3/15/2022 (updated 3/27/2024)
This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.
Posted 6/3/2022 (updated 3/27/2024)
This session highlighted the ways in which data from RCORP consortia are used, how service capacity and access have changed, and whether there is evidence that the health status of rural residents is improving. Additional data on telehealth utility, COVID-19 vaccination efforts, and drivers of Medication-Assisted Treatment (MAT) retention was highlighted.
Posted 6/6/2022 (updated 3/27/2024)
There are many pathways of recovery from substance use disorder, and all are cause for celebration. This panel featured diverse faces and voices representing a variety of recovery experience including elements of medications for opioid use disorder, alcohol-free recreation, harm reduction mutual aid, outdoor hobbies, yoga and meditation, recovery-supportive housing, collegiate recovery, 12-step mutual aid, and more.
Posted 6/7/2022 (updated 3/27/2024)
Cohort-Specific Sessions/Activities and Day 2 Wrap-Up
Posted 6/7/2022 (updated 3/27/2024)
Dr. Brooklyn discussed the following topics: the implementation of a Hub and Spoke model can lead to a significant increase in number of people with OUD treated in rural areas by providing resources for small and rural medical and behavioral health practices and a novel program to increase dosing compliance and security through the use of secure medication dispensers and a Smartphone app can increase access to MOUD in rural areas.
Posted 6/7/2022 (updated 3/27/2024)
This session highlighted the ways in which data from RCORP consortia are used, how service capacity and access have changed, and whether there is evidence that the health status of rural residents is improving. Additional data on telehealth utility, COVID-19 vaccination efforts, and drivers of MAT retention were highlighted. (Repeated from Day 1 Session 4A on Tuesday, April 5th).
Posted 8/2/2022 (updated 3/27/2024)
Innovative at their inception three decades ago, drug courts confront a practical and ethical obligation to reimagine some core practices and assumptions. A shifting legal and public health landscape means, for example, increased scrutiny of the courts’ focus on abstinence and mandated treatment, and the use of jail. This publication argues the most effective way for drug courts to evolve is by integrating the practices and principles of harm reduction